Nasonex, Mometasone Nasal News

Warsaw, Poland June 9, 2009 According to new data presented today for the first time, patients with seasonal allergic rhinitis experienced greater relief of nasal symptoms and equivalent relief of ocular symptoms with NASONEX Nasal Spray, 50 mcg* versus the antihistamine loratadine.

Warsaw, Poland June 9, 2009 Recently analyzed data demonstrate the benefits of adhering to a daily NASONEX Nasal Spray, 50 mcg* treatment regimen following initial symptom relief, including longer sustained relief of nasal symptoms and significantly fewer recurrences, compared with placebo.

This is the time of year to start considering some relief to your seasonal allergies.